연구성과로 돌아가기
JCR 2021 저널 목록 (1592 / 2039)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart International | TOUCH MEDICAL MEDIA LTD | 2036-2579 | 2036-2579 | ESCI | CARDIAC & CARDIOVASCULAR SYSTEMS | 147 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.06 | 187/208 | Q4 | 10.34 | 0.000 | 0.027 | N/A | N/A | 9 | 0.0% | 9.7 | 5.7 | 0 | 78.4% | 2025-04-21 11:32:40 | 바로가기 |
| Heart Views | WOLTERS KLUWER MEDKNOW PUBLICATIONS | 1995-705X | 0976-5123 | ESCI | CARDIAC & CARDIOVASCULAR SYSTEMS | 375 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.12 | 183/208 | Q4 | 12.26 | 0.000 | 0.098 | N/A | N/A | 53 | 84.9% | 5.4 | 9.0 | 45 | 54.8% | 2025-04-21 11:32:38 | 바로가기 |
| Heat Transfer | WILEY | 2688-4534 | 2688-4542 | ESCI | THERMODYNAMICS | 2,388 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.72 | 25/77 | Q2 | 68.18 | 0.001 | 0.240 | 0.373 | Q1 | 455 | 98.0% | 1.5 | 5.1 | 446 | 0.3% | 2025-04-21 15:15:57 | 바로가기 |
| Heat Transfer-Asian Research | WILEY | 1099-2871 | 1523-1496 | ESCI | THERMODYNAMICS | 1,553 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.68 | 26/77 | Q2 | 66.88 | 0.001 | 0.287 | 0.313 | Q1 | 0 | N/A | 2.8 | N/A | 0 | 0.8% | 2025-04-21 15:15:57 | 바로가기 |
| Hebrew Bible and Ancient Israel | MOHR SIEBECK | 2192-2276 | 2192-2284 | ESCI | RELIGION | 61 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.54 | 149/332 | Q2 | 55.27 | 0.000 | 0.086 | 0.399 | Q1 | 19 | 100.0% | N/A | 14.3 | 19 | 0.0% | 2025-04-21 13:45:40 | 바로가기 |
| HEGEL-STUDIEN | FELIX MEINER VERLAG | 0073-1587 | N/A | AHCI | PHILOSOPHY | 61 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.11 | 250/321 | Q4 | 22.27 | 0.000 | 0.010 | 0.129 | Q4 | 0 | N/A | N/A | N/A | 0 | 0.0% | 2025-04-21 13:35:38 | 바로가기 |
| HELIOS | TEXAS TECH UNIV PRESS | 0160-0923 | 1935-0228 | AHCI | CLASSICS | 109 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 1.59 | 9/58 | Q1 | 85.34 | 0.000 | 0.029 | 0.386 | Q3 | 7 | 100.0% | 17.7 | 11.9 | 7 | 0.0% | 2025-04-21 11:35:43 | 바로가기 |
| Hematologie | JOHN LIBBEY EUROTEXT LTD | 1264-7527 | 1950-6368 | ESCI | HEMATOLOGY | 25 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.01 | 94/94 | Q4 | 0.53 | 0.000 | 0.003 | 0.009 | Q4 | 30 | 43.3% | N/A | 4.1 | 13 | 6.4% | 2025-04-21 13:11:48 | 바로가기 |
| Hematology Reports | MDPI | 2038-8322 | 2038-8330 | ESCI | HEMATOLOGY | 288 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.17 | 82/94 | Q4 | 13.30 | 0.000 | 0.064 | 0.241 | Q3 | 23 | 91.3% | 5.3 | 6.3 | 21 | 93.2% | 2025-04-21 13:11:47 | 바로가기 |
| Hematology Transfusion and Cell Therapy | ELSEVIER | 2531-1379 | 2531-1379 | ESCI | HEMATOLOGY | 385 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.30 | 77/94 | Q4 | 18.62 | 0.001 | 0.138 | 0.402 | Q3 | 87 | 86.2% | 1.9 | 7.4 | 75 | 94.5% | 2025-04-21 13:11:47 | 바로가기 |
| Hematology Transfusion and Cell Therapy | ELSEVIER | 2531-1379 | 2531-1379 | ESCI | ONCOLOGY | 385 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.30 | 269/318 | Q4 | 15.57 | 0.001 | 0.138 | 0.402 | Q2 | 87 | 86.2% | 1.9 | 7.4 | 75 | 94.5% | 2025-04-21 13:31:29 | 바로가기 |
| HENRY JAMES REVIEW | JOHNS HOPKINS UNIV PRESS | 0273-0340 | 1080-6555 | AHCI | LITERATURE, BRITISH ISLES | 80 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.70 | 14/23 | Q3 | 41.30 | 0.000 | 0.031 | 0.140 | Q3 | 20 | 100.0% | N/A | 27.4 | 20 | 0.0% | 2025-04-21 13:19:26 | 바로가기 |
| Hepatic Medicine-Evidence and Research | DOVE MEDICAL PRESS LTD | 1179-1535 | 1179-1535 | ESCI | GASTROENTEROLOGY & HEPATOLOGY | 386 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.46 | 93/136 | Q3 | 31.99 | 0.000 | 0.105 | 0.747 | Q1 | 13 | 38.5% | 5.1 | 6.5 | 5 | 97.8% | 2025-04-21 13:08:45 | 바로가기 |
| Hepatic Oncology | FUTURE MEDICINE LTD | 2045-0923 | 2045-0931 | ESCI | ONCOLOGY | 308 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.63 | 171/318 | Q3 | 46.38 | 0.000 | 0.105 | 0.899 | Q1 | 7 | 71.4% | 4.3 | 4.6 | 5 | 100.0% | 2025-04-21 13:31:30 | 바로가기 |
| Herald of an Archivist | RUSSIAN SOC HISTORIANS & ARCHIVISTS | 2073-0101 | 2073-0101 | ESCI | HISTORY | 49 | N/A | N/A | 100.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.22 | 374/494 | Q4 | 24.39 | 0.000 | 0.068 | 0.071 | Q4 | 100 | 91.0% | N/A | 10.0 | 91 | 90.9% | 2025-04-21 13:13:19 | 바로가기 |
페이지 이동: